Florida Cancer Specialists & Research Institute Welcomes Dr. Charmion Patton as Senior Vice President
04/05/2021 | 11:00am EDT
Send by mail :
Message :
Required fields
Fort Myers, Fla., April 05, 2021 (GLOBE NEWSWIRE) Florida Cancer Specialists & Research Institute (FCS) is pleased to welcome Charmion Patton, EdD, PHR as Senior Vice President of People & Culture. In this newly created role, Dr. Patton will oversee the development of strategic and innovative culture initiatives to attract, engage and develop the FCS workforce, encompassing recruitment, organizational design, performance management, total rewards and HR compliance. She will also serve as the company’s Diversity & Inclusion Officer.
“Dr. Patton will play a critical role in advancing our FCS commitment to becoming an employer of choice,” said FCS CEO Nathan H. Walcker. “In partnership with executive and senior leaders, she will help ensure that our business decisions and actions set the stage for t
James Jackson, newly appointed Interim CEO of Alameda Health System. Photo courtesy of AHS.
The Alameda Health System (AHS) Board of Trustees recently approved the appointment of former AHS executive James Jackson as the system’s interim chief executive Officer. Jackson assumed the role on January 25
th after partnering on the transition with outgoing CEO Delvecchio Finley.
According to the AHS Board, Jackson was appointed to rebuild trust and resolve labor disputes, settle labor contracts and work with the Alameda County Board of Supervisors on a potential new AHS governance structure.
An Oakland native, Jackson previously served as the chief administrative officer at Alameda and San Leandro Hospitals until 2018. His ability to build authentic internal and external partnerships to advance AHS’s mission was a key factor in the board’s decision.
Introduction
In December 2020, California Attorney General Xavier Becerra was
announced to be President-Elect Joseph R. Biden, Jr. s
pick to lead the Department of Health and Human Services. The
California Attorney General s Office is the second largest
Justice Department in the United States, second only to the U.S.
Department of Justice, and California Attorney General Xavier
Becerra was the first Latino Attorney General in California s
history. Before becoming the Attorney General of California,
Becerra had a 24-year career in the U.S. House of
Representatives.
1 In 2017, Governor Jerry Brown
appointed Becerra to the last two years of Kamala Harris s term
January 25, 2021
Introduction
In December 2020, California Attorney General Xavier Becerra was announced to be President-Elect Joseph R. Biden, Jr.’s pick to lead the Department of Health and Human Services. The California Attorney General’s Office is the second largest Justice Department in the United States, second only to the U.S. Department of Justice, and California Attorney General Xavier Becerra was the first Latino Attorney General in California’s history. Before becoming the Attorney General of California, Becerra had a 24-year career in the U.S. House of Representatives.[1] In 2017, Governor Jerry Brown appointed Becerra to the last two years of Kamala Harris’s term as Attorney General, after she won election to the United States Senate. Now, Governor Gavin Newsom will appoint a successor to complete the remaining two years of Becerra’s term, assuming he is confirmed by the U.S. Senate.[2]
About R&Q R&Q is a non-life global specialty insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant secular growth opportunities. Legacy Insurance generates profits and capital extractions from expert management of legacy non-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niche and profitable program business, largely on behalf of highly rated reinsurers.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact